1
Return

Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil

delete2025-05-20
delete0
delete
OA
AI
C
Cynthia de Oliveira Ferreira *
A
André Luiz Leturiondo
C
Camila Gurgel dos Santos
J
Jaqueline Bentes da Silva
M
Mírian Carvalho de Souza
C
Catherine Bianca Oliveira Rego
G
Guilherme Caldas de Souza
P
Pinheiro, Thamires Bastos
G
Gisely Cardoso de Melo
P
Patrícia Sammarco Rosa
M
Marcelo Távora Mira
C
Charlotte Avanzi
C
Carolina Talhari
DOI:10.1128/aac.01550-24delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
Multidrug therapy for leprosy is highly effective and the recommended standard of care for leprosy worldwide. However, reports of antimicrobial resistance (AMR) have emerged globally. This study aimed to estimate the frequency of primary and secondary AMR associated with leprosy in patients treated at the Alfredo da Matta Foundation, Manaus, Amazonas, Brazil, as well as to determine the circulating subtypes of Mycobacterium leprae in this population. A total of 315 biopsy samples were investigated for variants in leprosy AMR-associated genes (rpoB, folP1, gyrA); a subset of 163 samples was also investigated for 5 additional candidate genes: gyrB, ctpC, ctpI, ribD, and fadD9. Patients were categorized into new cases, relapses, and suspected treatment failures. For statistical analysis, Pearson's chi-square or Fisher's exact test was employed for categorical variables, while mean and SD were calculated for continuous variables, with a significance level of 5%. Variant analysis detected 10 resistant M. leprae isolates displaying mutations in the rpoB (2, 0.6%) and folP1 (8, 2.5%) genes. In addition, variants in gyrB (1, 0.6%), ctpC (6, 3.7%), ribD (4, 2.4%), and fadD9 (15, 9.2%) were detected. Nine out of 10 resistant isolates were observed in the relapse group (P = 0,0014). Despite the low variant frequencies observed, variant detection highlights the need for expanded antimicrobial monitoring and surveillance. The impact of mutations in ribD and fadD9 on therapeutic response remains unclear, underscoring the need for further research. Genotyping revealed subtype-4 predominance (79.6%). Our findings highlight the importance of comprehensive AMR monitoring, particularly in relapse cases.
Keywords:
leprosy
antimicrobial resistance
DNA sequence analysis
Brazilian Amazon region

Journal

Antimicrobial Agents and Chemotherapy cover
Antimicrobial Agents and Chemotherapy
IF:
4.5
Papers:
2.3W
Citations:
6.2W

Organization

C
Colorado State Univ
Scholars:
921
Papers: 467
Citations: 146
F
fundacao hosp alfredo matta fuham
Scholars:
7
Papers: 1
Citations: 0
I
inst lauro souza lima
Scholars:
1
Papers: 1
Citations: 0
F
fundacao med trop dr heitor vieira
Scholars:
1
Papers: 1
Citations: 0
P
Pontificia Univ Catol Parana
Scholars:
5
Papers: 70
Citations: 0
U
univ estado amazonas uea
Scholars:
4
Papers: 2
Citations: 1
Cited Papers

Cited Papers

Citing Papers

Citing Papers